Aditum Bio and Leads Biolabs join forces to fight autoimmune …
Nov 7, 2024 · The U.S. company Aditum Bio and Chinese company Leads Biolabs today announced that they have founded Oblenio Bio, a new company that will develop a potentially …
Biopharmaceutical Manufacturing, Upstream, Downstream …
Jan 16, 2025 · News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream/downstream processing, cell culture and regulations
BridgeBio wins FDA Approval for cardiomyopathy treatment
Nov 26, 2024 · The exact prevalence of ATTR-CM is uncertain but is thought to be higher than previously thought. Estimates have increased from 5 in 100,000 people in 2004 to 35 per …
FDA approves first mesenchymal stromal cell therapy
Dec 19, 2024 · “Steroid-refractory acute graft-versus-host disease can have significant, wide-ranging health consequences, including damage to multiple organs, reduced quality of life and …
FDA removes clinical hold on Novavax’s COVID-19-influenza …
Nov 12, 2024 · The U.S. company Novavax announced yesterday that the FDA has removed the clinical hold placed on its COVID-19-influenza combination (CIC) vaccine and the stand-alone …
Eli Lilly's eczema drug receives FDA approval one year after its ...
Sep 17, 2024 · At the time, a representative from Eli Lilly stated that the company would work closely with the CRO and the FDA to address the agency’s feedback and make the drug …
Astellas licenses AviadoBio’s dementia gene therapy candidate
Oct 10, 2024 · “This strategic collaboration will combine our promising gene therapy candidate for FTD-GRN and delivery expertise with Astellas’ global capabilities in development and …
Nucleus RadioPharma secures Series A investment from AstraZeneca
Jun 6, 2024 · Nucleus RadioPharma, a leading player in the development, manufacturing, and supply chain management of radiopharmaceuticals, has announced a significant milestone …
The top 5 CDMOs developing advanced therapies
Jul 18, 2024 · Headquarters: Somerset, New Jersey, US. Founded: 2007. Catalent was set up when Blackstone acquired the pharmaceutical and services assets from Cardinal Health and …
BMS achieves FDA approval for schizophrenia drug Cobenfy
Oct 1, 2024 · Bristol Myers Squibb (BMS) acquired Karuna Therapeutics, the developer of KarXT, in a deal worth US $14.0 billion in equity value that completed earlier this year. The deal has …